OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, reported today ...
Tuesday, OpGen Inc (NASDAQ:OPGN) shares are trading higher after the company entered into a securities purchase agreement with a private investor, David Lazar, to acquire 3 million shares of Series E ...
As the newly appointed president and CEO of OpGen I want to take a moment to formally introduce myself and share the vision our new management team has for the company with regards to our business ...
The OpGen Gene Panel product tests for causes of antimicrobial and antibiotic resistance in hospital patients. The FDA approval, CEO Oliver Schacht said, will help it move away from research and ...
LabAnswer has announced the implementation of a cloud based, HIPAA compliant system to support OpGen’s newly launched clinical services laboratory. This CLIA certified laboratory will focus on ...
Elements of this announcement contain or may contain inside information within the meaning of Article 7(1) of the Market Abuse Regulation. The combined companies will have a broad commercial-stage ...
OpGen, Inc. has announced the appointment of Vadim Sapiro as chief information officer. In addition, the company announced the promotion and appointments of several key members of the executive ...
ROCKVILLE, Md., Aug. 12, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat ...
OpGen’s management believes that, given the abrupt change by the Chinese government in the first quarter of 2023 on their zero COVID policy, there is now a realistic opportunity for OpGen’s local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results